Arcus Biosciences Inc (RCUS) stock news · rev $247.0M
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
This RCUS news page leads with what Arcus Biosciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for RCUS yet. We will not pad this page with generic market recap.
Latest reported RCUS revenue for 2025-12-31 was $247.0M. Net income was -$353.0M. Revenue was down 4.3% from 2024-12-31 to 2025-12-31. RCUS currently screens at market cap $885.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RCUS stock page; for the tape open the quote page.
RCUS stock news FAQ
What are RCUS's latest revenue and net income?
Latest cached Arcus Biosciences Inc (RCUS) revenue for Dec 31, 2025 was $247.0M. Net income was -$353.0M. Statements: https://lician.com/financials/rcus
How did RCUS revenue change from the prior cached period?
Cached Arcus Biosciences Inc (RCUS) revenue was down 4.3% from $258.0M (Dec 31, 2024) to $247.0M (Dec 31, 2025). Statements: https://lician.com/financials/rcus
What is RCUS's market cap?
Arcus Biosciences Inc (RCUS) market cap is $885.2M on the latest cached fundamentals snapshot.
What kind of company is RCUS?
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Where is RCUS stock news listed?
Cached stock news for Arcus Biosciences Inc (RCUS) is listed at https://lician.com/news/rcus. Filings: https://lician.com/sec/rcus
Not investment advice.